These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15257002)

  • 1. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model.
    Urashima H; Okamoto T; Takeji Y; Shinohara H; Fujisawa S
    Cornea; 2004 Aug; 23(6):613-9. PubMed ID: 15257002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits.
    Urashima H; Takeji Y; Okamoto T; Fujisawa S; Shinohara H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):264-70. PubMed ID: 22304618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide suppresses TNF-α production and macrophage infiltration in the conjunctiva.
    Tajima K; Hattori T; Takahashi H; Katahira H; Narimatsu A; Kumakura S; Goto H
    Vet Ophthalmol; 2018 Jul; 21(4):347-352. PubMed ID: 29251403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of an Ultrafine Rebamipide Ophthalmic Suspension with High Transparency.
    Matsuda T; Hiraoka S; Urashima H; Ogura A; Ishida T
    Biol Pharm Bull; 2017; 40(5):665-674. PubMed ID: 28458352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
    Tabuchi N; Toshida H; Koike D; Odaka A; Suto C; Ohta T; Murakami A
    J Ocul Pharmacol Ther; 2017; 33(1):24-33. PubMed ID: 28009531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    Hori Y; Kageyama T; Sakamoto A; Shiba T; Nakamura M; Maeno T
    J Ocul Pharmacol Ther; 2017; 33(6):493-497. PubMed ID: 28346860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells.
    Takeji Y; Urashima H; Aoki A; Shinohara H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):259-63. PubMed ID: 22335446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.
    Kawaguchi I; Kobayashi A; Higashide T; Takeji Y; Sakurai K; Kawaguchi C; Sugiyama K
    PLoS One; 2017; 12(10):e0186714. PubMed ID: 29049370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.
    Kojima T; Simsek C; Igarashi A; Aoki K; Higa K; Shimizu T; Dogru M; Tsubota K; Shimazaki J
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1675-1681. PubMed ID: 29625494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse.
    Ogawa M; Simsek C; Kojima T; Nagata T; Igarashi A; Kawakita T; Dogru M; Shimazaki J; Tsubota K
    Eye Contact Lens; 2019 Mar; 45(2):93-98. PubMed ID: 30365413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye.
    Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress.
    Simsek C; Kojima T; Nakamura S; Dogru M; Tsubota K
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
    Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
    Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model.
    Otake H; Kobayashi K; Kadowaki R; Kosaka T; Itahashi M; Tsubaki M; Matsuda M; Iwakiri N; Harata E; Nagai N
    Drug Des Devel Ther; 2024; 18():4345-4358. PubMed ID: 39359484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human corneal epithelial mucins by rebamipide.
    Itoh S; Itoh K; Shinohara H
    Curr Eye Res; 2014 Feb; 39(2):133-41. PubMed ID: 24073690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells.
    Ueta M; Sotozono C; Yokoi N; Kinoshita S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):688-93. PubMed ID: 23662915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
    Ueda K; Matsumiya W; Otsuka K; Maeda Y; Nagai T; Nakamura M
    BMC Ophthalmol; 2015 Jun; 15():58. PubMed ID: 26048396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.